Chuang, Wan-Long

Publishing since 1986 (Dinosaur)

Has published 162 publications in 25 years

Number of publications published per year by Chuang, Wan-Long. (Source : PubMed)

Distribution of publications types for Chuang, Wan-Long. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  McHutchison J, Goodman Z, Patel K, Makhlouf H, Rodriguez-Torres M, Shiffman M, Rockey D, Husa P, Chuang WL, Levine R, Jonas M, Theodore D, Brigandi R, Webster A, Schultz M, Watson H, Stancil B, Gardner S. Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection.  Gastroenterology  2010;138;4  
•  Marshall J, McEachern KA, Chuang WL, Hutto E, Siegel CS, Shayman JA, Grabowski GA, Scheule RK, Copeland DP, Cheng SH. Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy.  J. Inherit. Metab. Dis.  2010  
•  Dai CY, Huang JF, Hsieh MY, Chuang WL, Yu ML. Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.  Gut  2010;59;3  
•  Huang CF, Yang JF, Dai CY, Huang JF, Hou NJ, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL, Yu ML. Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.  J. Infect. Dis.  2010;201;5  
•  Dai CY, Ho CK, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Yu ML, Chuang WL. Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan.  J. Hepatol.  2010;52;2  
•  Wu KT, Yang JF, Chuang WL, Yu ML. Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: some issues.  J. Hepatol.  2010;52;2  
•  Dai CY, Chuang WL, Hsieh MY, Huang JF, Lin YY, Chu PY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML. Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients.  Antiviral Res.  2010;85;2  
•  Jeng JE, Tsai HR, Chuang LY, Tsai JF, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG. Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.  Medicine (Baltimore)  2009;88;6  
•  Hsieh MH, Ho CK, Hou NJ, Hsieh MY, Lin WY, Yang JF, Chiu CC, Huang JF, Chang NC, Wang CL, Dai CY, Chuang WL, Yu ML. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.  Int J Obes (Lond)  2009;33;11  
•  Huang CI, Wang LY, Yeh ML, Hsieh MY, Huang JF, Lin ZY, Chuang WL. Hepatocellular carcinoma associated with liver abscess.  Kaohsiung J. Med. Sci.  2009;25;10  

[ See timeline ] [ See all publications ]